We would like to inform all participants, speakers, and attendees that the ICPOC 2026 event scheduled during November 23-25, 2026 in Singapore and Online has been postponed. The decision has been made to ensure the best possible experience for everyone involved. The new dates will be announced soon and updated on our website. We sincerely appreciate your understanding and continued support.
For any queries, please contact: [email protected]
We are excited to bring you an even bigger and better event!
Please stay tuned for updated details, which will be shared soon.
University of Bern, Switzerland
Prof. Ren-Wang Peng is a cancer researcher specializing in translational oncology and therapeutic resistance. He earned his Ph.D. from the Chinese Academy of Sciences and has conducted research at the Max Planck Institute and ETH Zürich. His work focuses on lung cancer and mesothelioma, with an emphasis on cancer stem cells and drug resistance mechanisms. Prof. Peng has published extensively in leading scientific journals and collaborates internationally on cancer research initiatives. He is currently an Associate Professor and Lab Head at the University Hospital of Bern (Inselspital) and a faculty member at the University of Bern’s Faculty of Medicine.
Oral Presentation (In-Person)
Title: Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer
© 2026 Mathews International LLC. All rights reserved.
